TRAW Traws Pharma, Inc.

Fundamentals / CIK 0001130598 / USD

Traws Pharma, Inc. reported $2.79M in revenue and a net loss of $22.31M for the fiscal year ended December 31, 2025 (up 1134.5% year over year), with a -798.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRAW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$26.62M$13.31M$0-$156.5MFY 2016 Revenue: $5.55MFY 2016 Net Income: -$19.67M2016FY 2017 Revenue: $787KFY 2017 Net Income: -$24.09M2017FY 2018 Revenue: $1.23MFY 2018 Net Income: -$20.57M2018FY 2019 Revenue: $2.18MFY 2019 Net Income: -$21.50M2019FY 2020 Revenue: $231KFY 2020 Net Income: -$25.16M2020FY 2021 Revenue: $226KFY 2021 Net Income: -$16.16M2021FY 2022 Revenue: $226KFY 2022 Net Income: -$18.96M2022FY 2023 Revenue: $226KFY 2023 Net Income: -$18.95M2023FY 2024 Revenue: $226KFY 2024 Net Income: -$166.5M2024FY 2025 Revenue: $2.79MFY 2025 Net Income: $9.17M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $2.79M $226K $226K $226K $226K $231K $2.18M $1.23M $787K $5.55M
Research & Development $12.14M $12.85M $11.43M $11.41M $7.30M $16.90M $15.54M $16.92M $19.12M $20.07M
Total Operating Expenses $20.66M $142.6M $20.52M $19.85M $16.72M $25.22M $23.88M $24.51M $26.52M $29.25M
Operating Income -$17.88M -$142.4M -$20.30M -$19.63M -$16.50M -$24.99M -$21.70M -$23.28M -$25.74M -$23.70M
EBITDA -$17.81M -$142.4M -$20.28M -$19.61M -$16.48M -$24.98M -$21.68M -$23.23M -$25.65M -$23.61M
Interest Income $455K $510K $1.39M $651K -- -- -- -- -- --
Income Before Tax $9.17M -$166.5M -$18.95M -$18.96M -$16.16M -$25.15M -$21.49M -$20.53M -$24.08M -$19.65M
Income Tax Expense -- -- -- -- -- $4.0K $10K -$124K $13K $14K
Net Income $9.17M -$166.5M -$18.95M -$18.96M -$16.16M -$25.16M -$21.50M -$20.57M -$24.09M -$19.67M
Basic EPS $0.83 -$35.21 -$22.57 -$22.75 -$24.00 -$54.25 -$558.75 -$1,871.25 -$15,056.25 -$24,975.00
Diluted EPS $0.82 -$35.21 -$22.57 -$22.75 -$24.00 -$54.25 -$558.75 -$1,871.25 -$15,056.25 -$24,975.00
Basic Shares Outstanding 8.2M 1.6M 839.6K 836.3K 673.3K 464.1K 38.4K 11.0K 1.6K 787
Diluted Shares Outstanding 8.4M 1.6M 839.6K 836.3K 673.3K 464.1K 38.4K 11.0K 1.6K 787

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $2.73M $57K $56K
Research & Development $1.83M $2.29M $4.91M $5.04M $2.31M $2.29M $2.51M $1.86M
Total Operating Expenses $3.60M $4.37M $6.95M $7.37M $4.05M $3.98M $5.26M $5.33M
Operating Income -$3.60M -$4.37M -$6.95M -$7.37M -$4.05M -$1.25M -$5.20M -$5.28M
EBITDA -$3.56M -$4.32M -$6.90M -$7.32M -$4.04M -$1.25M -$5.20M -$5.28M
Net Income -$3.55M -$4.21M -$7.11M -$7.44M -$3.96M -$915K $21.49M -$29.92M
Basic EPS -$0.18 -$0.23 -$0.53 -- -$0.34 -$0.11 $2.17 --
Diluted EPS -$0.18 -$0.23 -$0.53 -- -$0.34 -$0.11 $2.09 --
Basic Shares Outstanding 17.0M 15.9M 10.6M -- 8.8M 5.8M 7.0M --
Diluted Shares Outstanding 17.0M 15.9M 10.6M -- 8.8M 5.8M 7.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents -- -- $20.56M $38.52M -- -- -- -- -- $21.40M
Cash & Short-Term Investments -- -- $20.56M $38.52M -- -- -- -- -- $21.40M
Accounts Receivable, Net $3.79M $1.76M $18K $29K $28K $37K $98K $35K $59K $31K
Other Current Assets $89K $178K $401K $40K $35K $180K $140K $68K $77K $73K
Total Current Assets $7.98M $24.95M $22.66M $39.35M $55.43M $19.78M $23.47M $17.77M $4.90M $23.07M
Property, Plant & Equipment, Net $7.0K $10K $22K $24K $38K $52K $50K $9.0K $64K $152K
Intangible Assets $2.53M -- -- -- -- -- -- -- -- --
Other Non-Current Assets $104K $1.0K $1.0K $1.0K $10K $150K $150K $149K $12K $12K
Total Non-Current Assets $2.64M $11K $23K $25K $48K $202K $200K $158K $76K $164K
Total Assets $10.62M $24.96M $22.68M $39.37M $55.48M $19.99M $23.67M $17.92M $4.98M $23.23M
Accounts Payable $5.65M $8.19M $5.62M $3.86M $2.76M $4.83M $4.27M $4.04M $6.19M $5.32M
Deferred Revenue (Current) -- $226K $226K $226K $226K $226K $226K $226K $455K $455K
Other Current Liabilities -- -- -- -- -- -- -- -- -- $198K
Total Current Liabilities $11.15M $11.53M $9.22M $8.05M $6.12M $10.02M $8.29M $8.44M $9.98M $10.16M
Deferred Revenue (Non-Current) -- $2.56M $2.79M $3.02M $3.24M $3.47M $3.69M $3.92M $4.09M $4.54M
Total Non-Current Liabilities $100K $45.06M $2.79M $3.02M $3.24M $3.79M $3.81M $4.10M $5.86M $7.95M
Total Liabilities $11.25M $56.59M $12.01M $11.06M $9.36M $13.81M $12.10M $12.54M $15.84M $18.11M
Common Stock $90K $36K $9.0K $209K $209K $124K $1.11M $57K $8.0K $68K
Retained Earnings -$640.0M -$649.2M -$482.6M -$463.7M -$444.7M -$428.6M -$403.4M -$381.9M -$362.3M -$338.2M
Accumulated Other Comp. Income $6.0K -$42K -$23K -$33K -$14K $14K -$18K -$12K $3.0K -$31K
Total Stockholders' Equity -- -- -- -- -- -- $11.57M $5.39M -$11.69M $4.30M
Total Equity -$629K -$31.63M $10.67M $28.31M $46.12M $6.17M $11.57M $5.39M -$10.86M $5.13M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Accounts Receivable, Net $2.19M $2.30M $1.69M $3.79M $1.99M $1.32M $1.65M $1.76M
Other Current Assets $92K $93K $138K $89K $92K $124K $183K $178K
Total Current Assets $4.98M $7.87M $5.67M $7.98M $9.62M $15.37M $18.86M $24.95M
Property, Plant & Equipment, Net $5.0K $5.0K $6.0K $7.0K $7.0K $8.0K $9.0K $10K
Intangible Assets $2.40M $2.44M $2.48M $2.53M $2.57M -- -- --
Other Non-Current Assets $142K $1.0K $1.0K $104K $240K $244K $198K $1.0K
Total Non-Current Assets $2.54M $2.45M $2.49M $2.64M $2.82M $252K $207K $11K
Total Assets $7.52M $10.31M $8.16M $10.62M $12.44M $15.62M $19.06M $24.96M
Accounts Payable $6.65M $6.33M $7.67M $5.65M $5.11M $4.76M $7.66M $8.19M
Deferred Revenue (Current) -- -- -- -- -- -- $226K $226K
Total Current Liabilities $9.64M $9.73M $13.21M $11.15M $7.89M $7.35M $10.40M $11.53M
Deferred Revenue (Non-Current) -- -- -- -- -- -- $2.51M $2.56M
Total Non-Current Liabilities $8.0K $44K $259K $100K $11K $8.0K $2.66M $45.06M
Total Liabilities $9.65M $9.78M $13.47M $11.25M $7.90M $7.36M $13.06M $56.59M
Common Stock $153K $152K $101K $90K $71K $71K $50K $36K
Retained Earnings -$654.8M -$651.3M -$647.1M -$640.0M -$632.5M -$628.6M -$627.7M -$649.2M
Accumulated Other Comp. Income -$7.0K -$5.0K -$2.0K $6.0K $6.0K $9.0K -$19K -$42K
Total Equity -$2.13M $535K -$5.31M -$629K $4.54M $8.26M $6.00M -$31.63M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $9.17M -$166.5M -$18.95M -$18.96M -$16.16M -$25.16M -$21.50M -$20.41M -$24.09M -$19.67M
Depreciation & Amortization $61K $12K $16K $14K $14K $13K $14K $55K $88K $96K
Stock-Based Compensation $728K $1.39M $1.30M $1.17M $576K $369K $1.05M $1.15M $1.71M $3.93M
Change in Receivables -$2.03M -$1.75M $11K -$1.0K $9.0K $61K -$63K $24K -$28K $1.47M
Change in Payables -$612K $646K $1.76M $1.10M -$2.08M $562K $232K -$1.45M $863K $1.90M
Operating Cash Flow -$18.18M -$29.79M -$17.93M -$16.29M -$19.49M -$23.07M -$20.83M -$22.70M -$23.82M -$15.81M
Capital Expenditure -$2.58M -$3.65M -$14K -- -- -$15K -$55K -- -- --
Free Cash Flow -$20.77M -$33.44M -$17.95M -- -- -$23.09M -$20.89M -- -- --
Investing Cash Flow -$2.58M -$3.65M -$14K -- -- -$15K -$55K -- -- --
Common Stock Issued $5.58M -- -- -- $55.04M $9.06M $21.76M $35.07M -- --
Financing Cash Flow $3.20M $33.98M -- -- $55.56M $19.36M $26.65M $35.66M $6.36M $17.42M
Net Change in Cash -$17.52M $517K -$17.94M -$16.31M $36.05M -$3.70M $5.76M $12.95M -$17.43M $1.60M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.70M -$3.05M -$7.11M -$7.44M -$3.96M -$915K $21.49M -$29.92M
Depreciation & Amortization $43K $44K $44K $44K $15K $1.0K $1.0K $2.0K
Stock-Based Compensation $795K $816K $634K $327K $135K $105K $161K $334K
Change in Receivables $3.10M -$3.60M $2.11M -$1.80M -$668K $331K $111K --
Change in Payables $464K -$1.48M $2.01M $2.47M $524K -$3.00M -$605K $793K
Operating Cash Flow -$2.48M -$7.50M -$2.58M -$2.76M -$4.01M -$5.98M -$5.44M -$4.04M
Common Stock Issued $91K $120K $1.90M $2.09M $116K $3.26M $122K --
Financing Cash Flow -$197K $9.39M $1.90M $158K -$62K $3.10M $13K --
Net Change in Cash -$2.68M $1.88M -$687K -$2.60M -$6.66M -$2.86M -$5.40M $15.93M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -640.7% -62997.3% -8981.4% -8684.5% -7299.1% -10819.5% -994.0% -1895.9% -3270.3% -427.4%
Net Profit Margin 328.7% -73682.7% -8384.1% -8391.2% -7151.8% -10890.5% -985.0% -1675.3% -3061.2% -354.6%
Return on Equity (ROE) -- -- -- -- -- -- -185.8% -381.9% -- -457.7%
Return on Assets (ROA) 86.4% -667.1% -83.5% -48.2% -29.1% -125.9% -90.8% -114.8% -483.9% -84.7%
Current Ratio 0.72x 2.16x 2.46x 4.89x 9.06x 1.97x 2.83x 2.11x 0.49x 2.27x
Quick Ratio -- -- 2.23x 4.79x -- -- -- -- -- 2.11x
Revenue Growth (YoY) +1134.5% 0.0% 0.0% 0.0% -2.2% -89.4% +77.8% +56.0% -85.8% -51.6%
5Y Revenue / Share Growth -31.9% -99.7% -99.8% -99.9% -100.0% -100.0% -97.3% -99.6% -100.0% -82.0%
10Y Revenue / Share Growth -100.0% -100.0% -100.0% -100.0% -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -640.7% -554.6% -698.1% -62715.9% -62997.3%
Net Profit Margin -- -- -- 328.7% -467.6% -613.9% -61696.0% -73682.7%
Return on Assets (ROA) -296.6% -220.3% -238.2% 86.4% -107.0% -114.1% -734.7% -667.1%
Current Ratio 0.52x 0.81x 0.43x 0.72x 1.22x 2.09x 1.81x 2.16x
Revenue Growth (YoY) -- -- -- -100.0% -100.0% +4694.7% +1.8% 0.0%
Net Income Growth (YoY) -- -- -133.1% -- -- -- -- --
EPS Growth (YoY) -- -- -124.4% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001130598) · from December 31, 2011 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal